Company Overview Solid State Pharma Inc. is a leader in the delivery of crystallization engineering services including screening and selection of polymorphs, co-crystals, salts, and crystallization process development and optimization. SPPI has experienced great success with the workflows that have been developed by combining fundamentals of crystallization and solid form science with years of experience and high throughput techniques. SSPI is conducting research on pharmaceutical crystallization engineering, polymorph screening, salt screening, co-crystal screening, chiral resolution, polymorph quantification, converting amorphous material to crystalline solid, chemical and crystallization process modeling. SSPI is working with a large number of pharmaceutical companies across the globe to help them fully understand the solid state and crystallization of their drug candidates. About Halifax, Nova Scotia Halifax is one of the most beautiful and historic Canadian cities. Located on the coast of the Atlantic Ocean, there are numerous parks, campsites, trails and rivers around the city for outdoor activities. City life is also superb. With a population of more than 400,000, Halifax is home to many cultural attractions, museums, art galleries, pubs and clubs. The city hosts three major universities and many community colleges. The beautiful Annapolis valley, which is home to the highest tides in the world, and also mountainous Cape Breton, are within a few hours of drive from Halifax. Halifax has one of the mildest winters in Canada as well as one of the most pleasant summers, which you can enjoy on the beautiful water front boardwalk. Summary “Scientist” position is a key contributor to the ongoing research at SSPI reporting to senior scientist or director. “Scientist” will contribute through conducting solid form screening experiments, characterizing the resulting materials, performing crystallization process development for active pharmaceutical ingredients and natural products through utilizing the physical chemistry knowledge and hands on experience. It is expected to have 70-80% lab work. Job Responsibility Design and perform high throughput polymorph screening, salt screening, solubility measurement and characterization under direction of senior scientist or director Design and perform crystallization process development, under direction of senior scientist or director, to achieve desired polymorph and specifications while meeting the specs Characterize the generated samples using X-ray Powder Diffraction (XRPD), Differential Scanning Calorimetry (DSC), Thermal Gravimetry Analysis (TGA), Liquid Nuclear Magnetic Resonance (NMR), dynamic vapor sorption (DVS), Optical Microscope, Scanning Electron Microscope (SEM), Particle Size Analyzer and HPLC Record all the details of experiments and analytical data Analyze data that are obtained from experiments and draw conclusions Use Deign of Experiment (DOE) software to perform statistical analysis of generated experimental data Write high quality weekly and final reports Routinely present the project results to the team through teleconference Follow the safety rules and housekeeping principles to maintain the working around clean and safe Other responsibilities as assigned Education & Experience PhD in chemistry, chemical Engineering, pharmaceutical sciences or related in the areas of crystallization engineering, physical chemistry, formulation, analytical chemistry, solid state characterization or organic chemistry. Skills Laboratory techniques for conducting wet chemistry experiments Knowledge of technical report writing is a must Knowledge of XRPD, DSC, TGA, STDA, SEM, DVS, NMR, HPLC and particle size analyzer is a plus Knowledge of crystallization engineering and solid form screening principles is a plus Knowledge of Process Analytical Technologies (PAT) tools is a plus. Specifically, FBRM, React-IR and PVM Knowledge of statistical Design of Experiment (DOE) is a plus Experience with DOE software, e.g. Design Expert is a plus Ability to use Microsoft office software is a must Excellent communication skills and the ability to present the result are required Physical Demands While performing the responsibilities of the job, the employee is required to talk, hear, see, stand, walk, sit, smell and use hands and fingers, to handle or feel. The employee is occasionally required to pick up ordinary weights. Closing date Open till filled Contact information Please e-mail your CV and cover letter describing why you are an ideal candidate: [email protected]]]>
BIONOVA CONTACT
#46 1344 Summer Street
Halifax, Nova Scotia
Canada B3H 0A8
Phone: 902-421-5705
Fax: 902-421-2733
Email: [email protected]
Halifax, Nova Scotia
Canada B3H 0A8
Phone: 902-421-5705
Fax: 902-421-2733
Email: [email protected]

Recent Posts
- NEWS RELEASE: Doris Grant appointed Vice President Business Development and Strategy at BioNova
- MARS VR Lab
- Workinsights
- NEWS RELEASE: BioNova Announces MycoFutures North Atlantic as the Winner of the Eleventh Annual BioInnovation Challenge (BIC) at BioPort 2021
- NEWS RELEASE: BioNova’s BioPort 2021 Conference for Health and Life Sciences Kicks-Off Today
Business Wire National BioTech News
- Oragenics Project to Develop a Variant-Agnostic Protein Antigen for Use in its COVID-19 Intranasal Vaccine Receives Funding from CQDM
- BIOQuébec and MassBio Renew Their Memorandum of Cooperation and Collaboration
- MEDiC Life Sciences Announces Collaboration with Bristol Myers Squibb on Tumor Target Discovery
- At BIO 2023, Canada Showcases Multiple Strengths as a Biopharma Powerhouse
- Breast Cancer Canada Announces $3-million Precision Prevention Progress Funding to Princess Margaret Cancer Centre
- Enveric Biosciences Receives Notice of Allowance from USPTO for EVM301 Series of Drug Candidates
- Cybin Announces Scientific Management Transition Following Achievement of Final Adelia Milestones
- Anaergia Signs Contract to Build State-of-the-Art Food Waste and Wastewater Sludge Co-Digestion Facility at Monterey One Water in California
- KEYTRUDA® (pembrolizumab) Plus Chemotherapy Significantly Improved Overall Survival Versus Chemotherapy Alone as First-Line Treatment for Unresectable Advanced Pleural Mesothelioma
- The Patient Safety Movement Foundation Concludes Its 10th Annual World Patient Safety, Science & Technology Summit
RECENT NEWS
- NEWS RELEASE: Doris Grant appointed Vice President Business Development and Strategy at BioNova February 9, 2023
- MARS VR Lab January 25, 2022
- Workinsights January 25, 2022
- NEWS RELEASE: BioNova Announces MycoFutures North Atlantic as the Winner of the Eleventh Annual BioInnovation Challenge (BIC) at BioPort 2021 November 8, 2021
- NEWS RELEASE: BioNova’s BioPort 2021 Conference for Health and Life Sciences Kicks-Off Today November 2, 2021
- NEWS RELEASE: BioNova Selects Eight Semi-Finalists to Participate in the 11th Annual BioInnovation Challenge August 24, 2021